# OnCo record hb0036 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hb0036/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hb0036" ;
  schema:name "HB0036"@en ;
  schema:alternateName "Anti-PD-L1 and anti-TIGIT bifunctional molecule"@en ;
  schema:description "HB0036 is an experimental investigational agent whose form is not stated in the registry from Shanghai Huaota Biopharmaceutical in phase 2 trials for non-small-cell lung cancer, aimed at PD-L1 and TIGIT."@en ;
  schema:url <https://onco.cc/drugs/hb0036/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HB0036> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "bifunctional antibody (anti-PD-L1/anti-TIGIT, per the sponsor's description; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/tigit/> ;
  onco:companies <https://onco.cc/companies/huabo-biopharm/> ;
  onco:trials <https://onco.cc/trials/nct05417321/> .